Treatment-Resistant Depression Market is Expected to Witness Robust Growth by 2036, Estimates DelveInsight

Source Summary

Key Treatment-Resistant Depression companies such as Navitor Pharmaceuticals, Supernus Pharmaceuticals, Novartis, Relmada Therapeutics, Beckley Psytech, COMPASS Pathways, Axsome Therapeutics, Celon Pharma, and others are driving innovation and growth in the global Treatment-Resistant Depression market. DelveInsight's "Treatment-Resistant Depression Market Insights, Epidemiology, and